Last reviewed · How we verify

NCT03709732

Living With Spinal Cord Injury.

Completed Last updated 27 April 2022
What this trial tests

trial testing no intervention in Spinal Cord Injuries in 2,654 participants. Completed in 30 July 2021.

Timeline
13 June 2019
Primary endpoint
30 July 2021
30 July 2021

Quick facts

Lead sponsorSt. Olavs Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment2,654
Start date13 June 2019
Primary completion30 July 2021
Estimated completion30 July 2021
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

St. Olavs Hospital

Who can join

16 and older, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Spinal Cord Injury (SCI) often drastically disrupts the lives of affected patients and their relatives and caregivers. This observational study will provide new knowledge on how patients and their family caregivers cope in the first years after injury in terms of work inclusion, participation, care giver burden and quality of life. This project will utilize Norwegian spinal cord injury quality register data and link clinical individual data from the quality register to national administrative data on employment and social insurance benefits.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other St. Olavs Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03709732.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing